Apple's ResearchKit could accelerate the pace at which industry approaches start-ups building products in the patient-facing part of health tech
The FDA approves generic Copaxone; AstraZeneca's experimental lung-cancer drug demonstrates that it can delay disease progression; PhRMA CEO John Castellani to step down
Kane & Finkel co-founder Bob Finkel launched a healthcare consultancy that will seek out limited-commitment projects.
Amgen's attempt to delay Zarxio was denied by a US District Court, which said the argument was speculative.
FDA approves Amgen heart failure drug; Pfizer halts breast-cancer drug trial over positive results; 30% of study participants asked docs about drug after seeing or reading an ad
Despite an FDA committee voting that AstraZeneca's diabetes medication carries an acceptable heart risk, analysts say a Merck study will determine the DPP-IV category's fate.
The drugmaker and patient network teamed up to establish a formal framework for deploying activity trackers for patients with MS and for capturing that data.
Late-stage results show Arzerra patients have a median progression-free survival rate almost double that of chemotherapy-only patients.
An FDA panel said heart risks should be part of Onglyza's label; the OIG will examine generic price increases; Abbott said its OTC glucose meter will save patients money
The company reported $7.7 billion in pharma revenue in the first quarter despite a drop in overall sales and profit.
Life Science Compliance Update will address growing compliance concerns in healthcare.
IBM takes on healthcare data; Mylan settled a lawsuit allowing it to launch generic Viagra by 2017; an FDA committee will meet today to discuss Onglyza
Americans spent 13.1% more on prescription medications in 2014 than they did in 2013, but recent launches indicate competition in the specialty drug space is going to heat up.
Apple is putting the power of clinical trials in our pockets with ResearchKit.
Physicians will be notified when patient care is not meeting national guidelines for COPD and asthma.
The 2015 healthcare agency questionnaire, for firms hoping to be featured in the Top 100 Agencies issue, is live. Click here to be considered.